EGF receptor targeted tumor imaging with biotin-PEG-EGF linked to 99mTc-HYNIC labeled avidin and streptavidin

Nuclear Medicine and Biology

Volumn 39, Issue 8, 2012, Pages 1122-1127

  Jung, Kyung Ho ^a,b   Park, Jin Won ^a   Paik, Jin Young ^a   Quach, Cung Hoa Thien ^a   Choe, Yearn Seong ^a,b   Lee, Kyung Han ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

99mTc; Avidin; Epidermal growth factor; Receptor imaging; Streptavidin

Indexed keywords

AVIDIN; BIOTIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HYDRAZINONICOTINAMIDE TC 99M; MACROGOL; RADIOPHARMACEUTICAL AGENT; STREPTAVIDIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; DIAGNOSTIC VALUE; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TARGETING; DRUG UPTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; RECEPTOR BINDING; SCINTIMAMMOGRAPHY; XENOTRANSPLANTATION;

ANIMALS; AVIDIN; BIOTIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DIAGNOSTIC IMAGING; EPIDERMAL GROWTH FACTOR; HUMANS; MICE; MODELS, MOLECULAR; ORGANOTECHNETIUM COMPOUNDS; POLYETHYLENE GLYCOLS; PROTEIN CONFORMATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; STREPTAVIDIN;

EID: 84867864819     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2012.06.007     Document Type: Article

References (26)

1. Yarden Y., Sliwkowski M.X. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001, 2:127-137.
2. Baselga J., Arteaga C.L. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J Clin Oncol 2005, 23:2445-2459.
3. Ke S., Wen X., Gurfinkel M., Charnsangavej C., Wallace S., Sevick-Muraca E.M., et al. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res 2003, 63:7870-7875.
4. Diagaradjane P., Orenstein-Cardona J.M., Colón-Casasnovas N.E., Deorukhkar A., Shentu S., Kuno N., et al. Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe. Clin Cancer Res 2008, 14:731-741.
5. 99mTc-Hydrazinonicotinamide epidermal growth factor-polyethylene glycol-quantum dot imaging allows quantification of breast cancer epidermal growth factor receptor expression and monitors receptor downregulation in response to cetuximab therapy. J Nucl Med 2011, 52:1457-1464.
6. Maecke H.R. Radiolabeled peptides in nuclear oncology: influence of peptide structure and labeling strategy on pharmacology. Ernst Schering Res Found Workshop 2005, 49:43-72.
7. Liu S. Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides. Adv Drug Deliv Rev 2008, 60:1347-1370.
8. Laitinen O.H., Nordlund H.R., Hytönen V.P., Kulomaa M.S. Brave new (strept)avidins in biotechnology. Trends Biotechnol 2007, 25(6):269-277.
9. Lesch H.P., Kaikkonen M.U., Pikkarainen J.T., Ylä-Herttuala S. Avidin-biotin technology in targeted therapy. Expert Opin Drug Deliv 2010, 7:551-564.
10. Wilchek M., Bayer E.A. The avidin-biotin complex in bioanalytical applications. Anal Biochem 1988, 171:1-32.
11. Hama Y., Urano Y., Koyama Y., Choyke P.L., Kobayashi H. Targeted optical imaging of cancer cells using lectin-binding BODIPY conjugated avidin. Biochem Biophys Res Commun 2006, 348:807-813.
12. Ponnazhagan S., Mahendra G., Kumar S., Thompson J.A., Castillas M. Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands. J Virol 2002, 76:12900-12907.
13. Han Z., Fu A., Wang H., Diaz R., Geng L., Onishko H., et al. Noninvasive assessment of cancer response to therapy. Nat Med 2008, 14:343-349.
14. Green N.M. Avidin. Adv Protein Chem 1975, 29:85-133.
15. DeLange R.J. Egg white avidin. I. Amino acid composition; sequence of the amino- and carboxyl-terminal cyanogen bromide peptides. J Biol Chem 1970, 245:907-916.
16. Bruch R.C., White H.B. Compositional and structural heterogeneity of avidin glycopeptides. Biochem 1982, 21:5334-5341.
17. Kang Y.S., Saito Y., Pardridge W.M. Pharmacokinetics of [3H]biotin bound to different avidin analogues. J Drug Target 1995, 3:159-165.
18. Rosebrough S.F. Pharmacokinetics and biodistribution of radiolabeled avidin Streptavidin and biotin. Nucl Med Biol 1993, 20:663-668.
19. Schechter B., Silberman V.R., Arnon R., Wilchek M. Tissue distribution of avidin and streptavidin injected to mice. Eur J Biochem 1990, 189:327-331.
20. Rosebrough S.F., Hartley D.F. Biochemical modification of streptavidin and avidin: in vitro and in vivo analysis. J Nucl Med 1996, 37:1380-1384.
21. Jeong J.M., Kinuya S., Paik C.H., Saga T., Sood V.K., Carrasquillo J.A., et al. Application of high affinity binding concept to radiolabel avidin with Tc-99m labeled biotin and the effect of pi on biodistribution. Nucl Med Biol 1994, 21:935-940.
22. Yao Z., Zhang M., Sakahara H., Nakamoto Y., Higashi T., Zhao S., et al. The relationship of glycosylation and isoelectric point with tumor accumulation of avidin. J Nucl Med 1999, 40:479-483.
23. Yao Z., Zhang M., Sakahara H., Saga T., Arano Y., Konishi J. Avidin targeting of intraperitoneal tumor xenografts. J Natl Cancer Inst 1998, 90:25-29.
24. Sato N., Kobayashi H., Saga T., Nakamoto Y., Ishimori T., Togashi K., et al. Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice. Clin Cancer Res 2001, 7:3606-3612.
25. Hnatowich D.J., Fritz B., Virzi F., Mardirossian G., Rusckowski M. Improved tumor localization with (strept)avidin and labeled biotin as a substitute for antibody. Nucl Med Biol 1993, 20(2):189-195.
26. Meyer D.L., Schultz J., Lin Y., Henry A., Sanderson J., Jackson J.M., et al. Reduced antibody response to streptavidin through site-directed mutagenesis. Protein Sci 2001, 10:491-503.